Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence and Food Effect of Daprodustat in Healthy Japanese Males
NCT03493386Phase 1Completed
- Sponsor
- GSK
- Start
- Apr 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of daprodustat in anemia (4 arms), sponsored by GSK. Primary endpoints: Area Under Plasma Concentration-time Curve From Zero Hours to Last Measurable Concentration at Day 2, Area Under Plasma Concentration-time Curve From Zero Hours Extrapolated to Infinity at Day 2 and 7 more. Started Apr 2018; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03493386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03493386.